[Myeloid/natural killer cell precursor acute leukemia initiated with pleural effusion]. 2002

Akiko Uchida, and Akira Miyata, and Youko Ikeda, and Naoyuki Nogami, and Soichirou Fujii, and Takesi Kikuchi, and Masayoshi Kibata
Department of Internal Medicine, Chugoku Central Hospital of the Mutual Aid Association of Public School Teachers, Fukuyama.

UI MeSH Term Description Entries
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015470 Leukemia, Myeloid, Acute Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES. Leukemia, Myelogenous, Acute,Leukemia, Nonlymphocytic, Acute,Myeloid Leukemia, Acute,Nonlymphocytic Leukemia, Acute,ANLL,Acute Myelogenous Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia with Maturation,Acute Myeloid Leukemia without Maturation,Leukemia, Acute Myelogenous,Leukemia, Acute Myeloid,Leukemia, Myeloblastic, Acute,Leukemia, Myelocytic, Acute,Leukemia, Myeloid, Acute, M1,Leukemia, Myeloid, Acute, M2,Leukemia, Nonlymphoblastic, Acute,Myeloblastic Leukemia, Acute,Myelocytic Leukemia, Acute,Myelogenous Leukemia, Acute,Myeloid Leukemia, Acute, M1,Myeloid Leukemia, Acute, M2,Nonlymphoblastic Leukemia, Acute,Acute Myeloblastic Leukemia,Acute Myeloblastic Leukemias,Acute Myelocytic Leukemia,Acute Myelocytic Leukemias,Acute Myelogenous Leukemias,Acute Myeloid Leukemias,Acute Nonlymphoblastic Leukemia,Acute Nonlymphoblastic Leukemias,Acute Nonlymphocytic Leukemia,Acute Nonlymphocytic Leukemias,Leukemia, Acute Myeloblastic,Leukemia, Acute Myelocytic,Leukemia, Acute Nonlymphoblastic,Leukemia, Acute Nonlymphocytic,Leukemias, Acute Myeloblastic,Leukemias, Acute Myelocytic,Leukemias, Acute Myelogenous,Leukemias, Acute Myeloid,Leukemias, Acute Nonlymphoblastic,Leukemias, Acute Nonlymphocytic,Myeloblastic Leukemias, Acute,Myelocytic Leukemias, Acute,Myelogenous Leukemias, Acute,Myeloid Leukemias, Acute,Nonlymphoblastic Leukemias, Acute,Nonlymphocytic Leukemias, Acute
D015703 Antigens, CD Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation. CD Antigen,Cluster of Differentiation Antigen,Cluster of Differentiation Marker,Differentiation Antigens, Leukocyte, Human,Leukocyte Differentiation Antigens, Human,Cluster of Differentiation Antigens,Cluster of Differentiation Markers,Antigen Cluster, Differentiation,Antigen, CD,CD Antigens,Differentiation Antigen Cluster,Differentiation Marker Cluster,Marker Cluster, Differentiation
D016066 Pleural Effusion, Malignant Presence of fluid in the PLEURAL CAVITY as a complication of malignant disease. Malignant pleural effusions often contain actual malignant cells. Malignant Pleural Effusion,Effusion, Malignant Pleural,Effusions, Malignant Pleural,Malignant Pleural Effusions,Pleural Effusions, Malignant

Related Publications

Akiko Uchida, and Akira Miyata, and Youko Ikeda, and Naoyuki Nogami, and Soichirou Fujii, and Takesi Kikuchi, and Masayoshi Kibata
April 2014, Zhongguo shi yan xue ye xue za zhi,
Akiko Uchida, and Akira Miyata, and Youko Ikeda, and Naoyuki Nogami, and Soichirou Fujii, and Takesi Kikuchi, and Masayoshi Kibata
December 2005, Cancer genetics and cytogenetics,
Akiko Uchida, and Akira Miyata, and Youko Ikeda, and Naoyuki Nogami, and Soichirou Fujii, and Takesi Kikuchi, and Masayoshi Kibata
September 2008, Medicina clinica,
Akiko Uchida, and Akira Miyata, and Youko Ikeda, and Naoyuki Nogami, and Soichirou Fujii, and Takesi Kikuchi, and Masayoshi Kibata
July 1999, Human pathology,
Akiko Uchida, and Akira Miyata, and Youko Ikeda, and Naoyuki Nogami, and Soichirou Fujii, and Takesi Kikuchi, and Masayoshi Kibata
February 2001, Leukemia research,
Akiko Uchida, and Akira Miyata, and Youko Ikeda, and Naoyuki Nogami, and Soichirou Fujii, and Takesi Kikuchi, and Masayoshi Kibata
June 2013, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Akiko Uchida, and Akira Miyata, and Youko Ikeda, and Naoyuki Nogami, and Soichirou Fujii, and Takesi Kikuchi, and Masayoshi Kibata
December 2023, Science advances,
Akiko Uchida, and Akira Miyata, and Youko Ikeda, and Naoyuki Nogami, and Soichirou Fujii, and Takesi Kikuchi, and Masayoshi Kibata
October 2013, Diagnostic cytopathology,
Akiko Uchida, and Akira Miyata, and Youko Ikeda, and Naoyuki Nogami, and Soichirou Fujii, and Takesi Kikuchi, and Masayoshi Kibata
July 1999, Leukemia research,
Akiko Uchida, and Akira Miyata, and Youko Ikeda, and Naoyuki Nogami, and Soichirou Fujii, and Takesi Kikuchi, and Masayoshi Kibata
April 2012, Zhongguo shi yan xue ye xue za zhi,
Copied contents to your clipboard!